Interplay of TNF-α and IL-10 in regulating oxidative stress in isolated adult cardiac myocytes

Journal of Molecular and Cellular Cardiology

Volumn 41, Issue 6, 2006, Pages 1023-1030

  Kaur, Kuljeet ^a,b   Sharma, Anita K ^a,b   Dhingra, Sanjiv ^a,b   Singal, Pawan K ^a,b  

^a ST BONIFACE GENERAL HOSPITAL RESEARCH CENTRE   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Antioxidant enzyme; Congestive heart failure; Interleukin 10; Oxidative stress; Tumor necrosis factor

Indexed keywords

CATALASE; CREATINE KINASE; GLUTATHIONE PEROXIDASE; HYDROGEN PEROXIDE; INTERLEUKIN 10; MANGANESE SUPEROXIDE DISMUTASE; MESSENGER RNA; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CELL DAMAGE; CONCENTRATION RESPONSE; CONTROLLED STUDY; HEART INJURY; HEART MUSCLE CELL; LIPID PEROXIDATION; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; STATISTICAL SIGNIFICANCE;

ANIMALS; ANTIOXIDANTS; BASE SEQUENCE; CATALASE; CREATINE KINASE; DNA PRIMERS; GLUTATHIONE PEROXIDASE; HYDROGEN PEROXIDE; INTERLEUKIN-10; LIPID PEROXIDES; MALE; MYOCYTES, CARDIAC; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; RECOMBINANT PROTEINS; RNA, MESSENGER; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33751231104     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2006.08.005     Document Type: Article

References (40)

1. Teerlink J.R., Goldhaber S.Z., and Pfeffer M.A. An overview of contemporary etiologies of congestive heart failure. Am. Heart J. 121 (1991) 1852-1853
2. Paulus W.J. Cytokines and heart failure. Heart Fail Monit. 1 (2000) 50-56
3. Kaul N., Siveski-Iliskovic N., Hill M., Slezak J., and Singal P.K. Free radicals and the heart. J. Pharmacol. Toxicol. Methods 30 (1993) 55-67
4. Sacks T., Moldow C.F., Craddock P.R., Bowers T.K., and Jacob H.S. Oxygen radicals mediate endothelial cell damage by complement-stimulated granulocytes. An in vitro model of immune vascular damage. J. Clin. Invest. 61 (1978) 1161-1167
5. Ksontini R., MacKay S.L., and Moldawer L.L. Revisiting the role of tumor necrosis factor alpha and the response to surgical injury and inflammation. Arch. Surg. 133 (1998) 558-567
6. Torre-Amione G. Immune activation in chronic heart failure. Am. J. Cardiol. 95 (2005) 3C-8C
7. Irwin M.W., Mak S., Mann D.L., Qu R., Penninger J.M., Yan A., et al. Tissue expression and immunolocalization of tumor necrosis factor-alpha in postinfarction dysfunctional myocardium. Circulation 99 (1999) 1492-1498
8. Bolger A.P., Sharma R., von Haehling S., Doehner W., Oliver B., Rauchhaus M., et al. Effect of interleukin-10 on the production of tumor necrosis factor-alpha by peripheral blood mononuclear cells from patients with chronic heart failure. Am. J. Cardiol. 90 (2002) 384-389
9. Schottelius A.J., Mayo M.W., Sartor R.B., and Baldwin Jr. A.S. Interleukin-10 signaling blocks inhibitor of kappaB kinase activity and nuclear factor kappaB DNA binding. J. Biol. Chem. 274 (1999) 31868-31874
10. Dokka S., Shi X., Leonard S., Wang L., Castranova V., and Rojanasakul Y. Interleukin-10-mediated inhibition of free radical generation in macrophages. Am. J. Physiol.: Lung Cell Mol. Physiol. 280 (2001) L1196-L1202
11. Mulligan M.S., Jones M.L., Vaporciyan A.A., Howard M.C., and Ward P.A. Protective effects of L-4 and IL-10 against immune complex-induced lung injury. J. Immunol. 151 (1993) 5666-5674
12. Shanley T.P., Schmal H., Friedl H.P., Jones M.L., and Ward P.A. Regulatory effects of intrinsic IL-10 in IgG immune complex-induced lung injury. J. Immunol. 154 (1995) 3454-3460
13. Ahmed S.T., and Ivashkiv L.B. Inhibition of IL-6 and IL-10 signaling and Stat activation by inflammatory and stress pathways. J. Immunol. 165 (2000) 5227-5237
14. Larrick J.W., and Wright S.C. Native cytokine antagonists. Bailliere's Clin. Haematol. 5 (1992) 681-702
15. Kaur K., Sharma A.K., and Singal P.K. Significance of Changes in TNF-{alpha} and IL-10 levels in the progression of heart failure subsequent to Myocardial Infarction. Am. J. Physiol. Heart Circ. Physiol. 291 (2006) 4106-4113
16. Lou H., Kaur K., Sharma A.K., and Singal P.K. Adriamycin-induced oxidative stress, activation of MAP kinases and apoptosis in isolated cardiomyocytes. Pathophysiology 13 (2006) 103-109
17. Khaper N., Kaur K., Li T., Farahmand F., and Singal P.K. Antioxidant enzyme gene expression in congestive heart failure following myocardial infarction. Mol. Cell. Biochem. 251 (2003) 9-15
18. Agardh C.D., Israelsson B., Thuesen-Olesen B., and Agardh E. Application of quantitative competitive polymerase chain reaction for measurements of mRNA from antioxidative enzymes in the diabetic rat retina and kidney. Metabolism 51 (2002) 1279-1284
19. Khaper N., and Singal P.K. Modulation of oxidative stress by a selective inhibition of angiotensin II type 1 receptors in MI rats. J. Am. Coll. Cardiol. 37 (2001) 1461-1466
20. Swift L.M., and Sarvazyan N. Localization of dichlorofluorescin in cardiac myocytes: implications for assessment of oxidative stress. Am. J. Physiol.: Heart Circ. Physiol. 278 (2000) H982-H990
21. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72 (1976) 248-254
22. Comstock K.L., Krown K.A., Page M.T., Martin D., Ho P., Pedraza M., et al. LPS-induced TNF-alpha release from and apoptosis in rat cardiomyocytes: obligatory role for CD14 in mediating the LPS response. J. Mol. Cell. Cardiol. 30 (1998) 2761-2775
23. Wright G., Singh I.S., Hasday J.D., Farrance I.K., Hall G., Cross A.S., et al. Endotoxin stress-response in cardiomyocytes: NF-kappaB activation and tumor necrosis factor-alpha expression. Am. J. Physiol.: Heart Circ. Physiol. 282 (2002) H872-H879
24. Moore K.W., de Waal Malefyt R., Coffman R.L., and O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu. Rev. Immunol. 19 (2001) 683-765
25. Redondo P., Garcia-Foncillas J., Okroujnov I., and Bandres E. Alpha-MSH regulates interleukin-10 expression by human keratinocytes. Arch. Dermatol. Res. 290 (1998) 425-428
26. Nakamura K., Fushimi K., Kouchi H., Mihara K., Miyazaki M., Ohe T., et al. Inhibitory effects of antioxidants on neonatal rat cardiac myocyte hypertrophy induced by tumor necrosis factor-alpha and angiotensin. Circulation 98 (1998) 794-799
27. Suematsu N., Tsutsui H., Wen J., Kang D., Ikeuchi M., Ide T., et al. Oxidative stress mediates tumor necrosis factor-alpha-induced mitochondrial DNA damage and dysfunction in cardiac myocytes. Circulation 107 (2003) 1418-1423
28. Machida Y., Kubota T., Kawamura N., Funakoshi H., Ide T., Utsumi H., et al. Overexpression of tumor necrosis factor-alpha increases production of hydroxyl radical in murine myocardium. Am. J. Physiol.: Heart Circ. Physiol. 284 (2003) H449-H455
29. 2. J. Clin. Invest. 89 (1992) 794-802
30. Marcho Z., White J.E., Higgins P.J., and Tsan M.F. Tumor necrosis factor enhances endothelial cell susceptibility to oxygen toxicity: role of glutathione. Am. J. Respir. Cell Mol. Biol. 5 (1991) 556-562
31. Lin Z.F., Li X.K., Lin Y., Wu F., Liang L.M., and Fu X.B. Protective effects of non-mitogenic human acidic fibroblast growth factor on hydrogen peroxide-induced damage to cardiomyocytes in vitro. World J. Gastroenterol. 11 (2005) 5492-5497
32. Kang K.A., Chae S., Koh Y.S., Kim J.S., Lee J.H., You H.J., et al. Protective effect of puerariae radix on oxidative stress induced by hydrogen peroxide and streptozotocin. Biol. Pharm. Bull. 28 (2005) 1154-1160
33. Wong G.H., and Goeddel D.V. Induction of manganous superoxide dismutase by tumor necrosis factor: possible protective mechanism. Science 242 (1988) 941-944
34. Czaja M.J., Schilsky M.L., Xu Y., Schmiedeberg P., Compton A., Ridnour L., et al. Induction of MnSOD gene expression in a hepatic model of TNF-alpha toxicity does not result in increased protein. Am. J. Physiol. 266 (1994) G737-G744
35. Yasmineh W.G., Parkin J.L., Caspers J.I., and Theologides A. Tumor necrosis factor/cachectin decreases catalase activity of rat liver. Cancer Res. 51 (1991) 3990-3995
36. Gunnett C.A., Heistad D.D., Berg D.J., and Faraci F.M. IL-10 deficiency increases superoxide and endothelial dysfunction during inflammation. Am. J. Physiol.: Heart Circ. Physiol. 279 (2000) H1555-H1556
37. Gougerot-Podicalo M.A., Elbim C., and Chollet-Martin S. Modulation of the oxidative burst of human neutrophils by pro- and anti-inflammatory cytokines. Pathol. Biol. (Paris) 44 (1996) 36-41
38. Koken T., Serteser M., Kahraman A., Akbulut G., and Dilek O.N. Which is more effective in the prevention of renal ischemia-reperfusion-induced oxidative injury in the early period in mice: interleukin (IL)-10 or anti-IL-12?. Clin. Biochem. 37 (2004) 50-55
39. Chen W.F., and Zlotnik A. IL-10: a novel cytotoxic T cell differentiation factor. J. Immunol. 147 (1991) 528-534
40. Shibata Y., Foster L.A., Kurimoto M., Okamura H., Nakamura R.M., Kawajiri K., et al. Immunoregulatory roles of IL-10 in innate immunity: IL-10 inhibits macrophage production of IFN-gamma-inducing factors but enhances NK cell production of IFN-gamma. J. Immunol. 161 (1998) 4283-4288